Regeneron Pharmaceuticals
REGN
#269
Rank
$66.16 B
Marketcap
$615.24
Share price
-0.14%
Change (1 day)
18.79%
Change (1 year)

Market capitalization of Regeneron Pharmaceuticals (REGN)

Market cap: $66.16 Billion

As of January 2022 Regeneron Pharmaceuticals has a market cap of $66.16 Billion. This makes Regeneron Pharmaceuticals the world's 269th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Regeneron Pharmaceuticals from 2001 to 2022

Year Market cap Change
2022$66.16 B-1.62%
2021$67.25 B30.46%
2020$51.55 B24.5%
2019$41.40 B1.7%
2018$40.71 B0.79%
2017$40.39 B4.33%
2016$38.71 B-31.85%
2015$56.81 B35.19%
2014$42.02 B53.15%
2013$27.43 B64.85%
2012$16.64 B224.35%
2011$5.13 B74.8%
2010$2.93 B49.69%
2009$1.96 B34.11%
2008$1.46 B-23.21%
2007$1.90 B45.08%
2006$1.31 B46.27%
2005$0.89 B74.43%
2004$0.51 B-37.05%
2003$0.81 B-0.78%
2002$0.82 B-33.46%
2001$1.23 B

End of Day market cap according to different sources

On Jan 15th, 2022 the market cap of Regeneron Pharmaceuticals was reported to be:

$66.16 Billion
by Yahoo Finance
$66.16 Billion
by CompaniesMarketCap
$66.16 Billion
by Nasdaq
$66.16 Billion
by Reuters
$65.04 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap difference Country
$441.85 B 567.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$202.56 B 206.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$132.57 B 100.36%๐Ÿ‡บ๐Ÿ‡ธ USA
$130.71 B 97.56%๐Ÿ‡ซ๐Ÿ‡ท France
$35.15 B-46.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$17.76 B-73.16%๐Ÿ‡บ๐Ÿ‡ธ USA